These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14327998)

  • 1. NONSPECIFIC AND BETA-ADRENERGIC BLOCKING EFFECTS OF ALDERLIN IN ANGINA PECTORIS.
    STRAIT GB; BRUCE RA
    Am Heart J; 1965 Aug; 70():150-6. PubMed ID: 14327998
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF A BETA-ANDRENERGIC-BLOCKING AGENT (NETHALIDE) AND NITROGLYCERIN ON EXERCISE TOLERANCE IN ANGINA PECTORIS.
    MACALPIN RN; KATTUS AA; WINFIELD ME
    Circulation; 1965 Jun; 31():869-75. PubMed ID: 14297521
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 4. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram.
    Prichard BN; Aellig WH; Richardson GA
    Postgrad Med J; 1970 Nov; ():Suppl:77-85. PubMed ID: 4395464
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of adrenergic beta-blocking drugs in angina pectoris.
    Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
    Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study.
    Sealey BJ; Liljedal J; Nyberg G; Ablad B
    Br Heart J; 1971 Jul; 33(4):481-8. PubMed ID: 4397626
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
    Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
    Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 11. PRONETHALOL ("ALDERLIN") A BETA ADRENERGIC INHIBITOR: PHARMACOLOGICAL OBSERVATIONS AND TRIAL IN ANGINA PECTORIS.
    BARNETT AJ; BRANDSTATER ME
    Med J Aust; 1964 May; 1():714-6. PubMed ID: 14159537
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a cardio-selective beta-adrenergic blocker (I.C.I. 50172) at exercise in angina pectoris.
    Areskog NH; Adolfsson L
    Br Med J; 1969 Jun; 2(5657):601-3. PubMed ID: 5798470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECT OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS: PRELIMINARY REPORT.
    HAMER J; GRANDJEAN T; MELENDEZ L; SOWTON GE
    Br Med J; 1964 Sep; 2(5411):720-3. PubMed ID: 14172034
    [No Abstract]   [Full Text] [Related]  

  • 14. [Load insufficiency of the heart due to beta receptor blocking agents].
    Froer KL; König E; Grünberg G
    Med Klin; 1969 Sep; 64(37):1663-8. PubMed ID: 4390887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 16. Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.
    Amsterdam EA; Hughes JL; DeMaria AN; Zelis R; Mason DT
    Am J Cardiol; 1974 May; 33(6):737-43. PubMed ID: 4151042
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind three-dose trial of oral alprenolol in angina pectoris.
    Sowton E; Smithen C
    Br Heart J; 1971 Jul; 33(4):601-6. PubMed ID: 4397627
    [No Abstract]   [Full Text] [Related]  

  • 18. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.